Cargando…
Treatment of Long-Haul COVID Patients With Off-Label Acyclovir
The SARS-CoV-2 virus (COVID-19) became a global pandemic in March 2020. This novel, highly infectious virus caused millions of infections and deaths around the world. Currently, there are few medications that are available for the treatment of COVID-19. Those affected are most commonly given support...
Autores principales: | German, Emily R, Jairath, Meera K, Caston, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205150/ https://www.ncbi.nlm.nih.gov/pubmed/37228547 http://dx.doi.org/10.7759/cureus.37926 |
Ejemplares similares
-
Off-label Sodium Oxybate in Childhood Narcolepsy: A Comprehensive Report
por: Miskoff, Jeffrey A, et al.
Publicado: (2018) -
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
por: Hayward, Gail, et al.
Publicado: (2021) -
Guideline Daily Amounts Versus Nutri-Score Labeling: Perceptions of Greek Consumers About Front-of-Pack Label
por: Kontopoulou, Lamprini, et al.
Publicado: (2022) -
Diagnosis and Long-term Management of Uromodulin Kidney Disease
por: Wheeler, Emily, et al.
Publicado: (2019) -
Corona With Lyme: A Long COVID Case Study
por: Thor, Danielle C, et al.
Publicado: (2023)